Ms. Hu is a Partner in the Beijing office of Haiwen & Partners. Her practice focuses on private equity investment, mergers and acquisitions.
題21-1_畫板 1 副本FA957310F08241619B67FAAC4823E9AE.png)
題21-1_畫板 114202E035D7D448C854A98012E0CB5BF.png)
Ms. Hu is a Partner in the Beijing office of Haiwen & Partners. Her practice focuses on private equity investment, mergers and acquisitions.
Ms. Hu joined Haiwen in 2021. Before that, Shanshan practiced law for 7 years with another renowned law firm in China.
Ms. Hu has represented multinational corporations, both domestic and international private equity firms, including Hillhouse, Alibaba, Ant Group, XiangHe Capital, Baidu Ventures, and SAIF Partners, etc. for their PE investments. She has also assisted numerous companies in their equity financing ranging from seed rounds to later stages, covering industry sectors such as artificial intelligence, semiconductors, biomedicine, etc.
In the area of M&A transactions, Ms. Hu’s recent representative experience includes representing Cowell Health in its acquisition of several pharmacy retail chains, assisting Demant Group in its acquisition of Shengwang (a Chinese hearing aid fitting chain network enterprise), advising Baring Asia on the sale of HCP Group, and providing services for the privatization of Suchuang Gas.
Chinese Bar
Ms. Hu obtained her LL.B. degree and LL.M. degree from China University of Political Science and Law in 2012 and 2015, respectively.
Her native language is Mandarin Chinese, and she speaks English fluently.
Beijing ICP No. 05019364-1 Beijing Public Network Security 110105011258